Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.
Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR. Stinchcomb AL, et al. J Pharm Pharmacol. 2004 Mar;56(3):291-7. doi: 10.1211/0022357022791. J Pharm Pharmacol. 2004. PMID: 15025853
Transdermal prodrug concepts: permeation of buprenorphine and its alkyl esters through hairless mouse skin and influence of vehicles.
Imoto H, Zhou Z, Stinchcomb AL, Flynn GL. Imoto H, et al. Among authors: stinchcomb al. Biol Pharm Bull. 1996 Feb;19(2):263-7. doi: 10.1248/bpb.19.263. Biol Pharm Bull. 1996. PMID: 8850319
Permeation of buprenorphine and its 3-alkyl-ester prodrugs through human skin.
Stinchcomb AL, Paliwal A, Dua R, Imoto H, Woodard RW, Flynn GL. Stinchcomb AL, et al. Pharm Res. 1996 Oct;13(10):1519-23. doi: 10.1023/a:1016079513007. Pharm Res. 1996. PMID: 8899844
In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation.
Challapalli PV, Stinchcomb AL. Challapalli PV, et al. Among authors: stinchcomb al. Int J Pharm. 2002 Jul 25;241(2):329-39. doi: 10.1016/s0378-5173(02)00262-4. Int J Pharm. 2002. PMID: 12100860
Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin.
Stinchcomb AL, Swaan PW, Ekabo O, Harris KK, Browe J, Hammell DC, Cooperman TA, Pearsall M. Stinchcomb AL, et al. J Pharm Sci. 2002 Dec;91(12):2571-8. doi: 10.1002/jps.10239. J Pharm Sci. 2002. PMID: 12434400
Xenobiotic bioconversion in human epidermis models.
Stinchcomb AL. Stinchcomb AL. Pharm Res. 2003 Aug;20(8):1113-8. doi: 10.1023/a:1025024309223. Pharm Res. 2003. PMID: 12948006 Review.
Liquid chromatographic-mass spectrometric quantitation of Delta9-tetrahydrocannabinol and two metabolites in pharmacokinetic study plasma samples.
Valiveti S, Stinchcomb AL. Valiveti S, et al. Among authors: stinchcomb al. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Apr 25;803(2):243-8. doi: 10.1016/j.jchromb.2003.12.024. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 15063332
In vitro/in vivo correlation studies for transdermal delta 8-THC development.
Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. Valiveti S, et al. Among authors: stinchcomb al. J Pharm Sci. 2004 May;93(5):1154-64. doi: 10.1002/jps.20036. J Pharm Sci. 2004. PMID: 15067692
Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro.
Valiveti S, Kiptoo PK, Hammell DC, Stinchcomb AL. Valiveti S, et al. Among authors: stinchcomb al. Int J Pharm. 2004 Jun 18;278(1):173-80. doi: 10.1016/j.ijpharm.2004.03.009. Int J Pharm. 2004. PMID: 15158959
A duplex "Gemini" prodrug of naltrexone for transdermal delivery.
Hammell DC, Hamad M, Vaddi HK, Crooks PA, Stinchcomb AL. Hammell DC, et al. Among authors: stinchcomb al. J Control Release. 2004 Jun 18;97(2):283-90. doi: 10.1016/j.jconrel.2004.03.020. J Control Release. 2004. PMID: 15196755
79 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback